(-)-Cannabidiol
Chemical Name: 2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
Purity: ≥99%
Biological Activity
(-)-Cannabidiol is a non-psychotropic constituent of cannabis that is anticonvulsive, antihyperalgesic and neuroprotective in vivo. GPR55 and weak CB1 antagonist (IC50 values are 0.445 and 3.35 μM), CB2 receptor inverse agonist and inhibitor of anandamide uptake (IC50 = 27.5 μM). Also inhibits FABPs and a weak agonist at TRP vanilloid receptors (EC50 = 3.5 μM). Reduces inflammation and LPS-induced cytokine production in cultured microglial cells.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
The response of PKD1L3/PKD2L1 to acid stimuli is inhibited by capsaicin and its pungent analogs.
Ishii S, Kurokawa A, Kishi M, Yamagami K, Okada S, Ishimaru Y, Misaka T
FEBS J., 2012;279(10):1857-70. -
The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg et al.
Br.J.Pharmacol., 2007;152:1092 -
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Costa et al.
Br.J.Pharmacol., 2004;143:247 -
Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Petitet et al.
Life Sci., 1998;63:PL1 -
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Thomas et al.
Br.J.Pharmacol., 2007;150:613 -
A personal retrospective: Elevating Anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs).
Deutsch
Front.Pharmacol., 2017;7:370
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for (-)-Cannabidiol
The citations listed below are publications that use Tocris products. Selected citations for (-)-Cannabidiol include:
5 Citations: Showing 1 - 5
-
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
Authors: Panja Et al.
Neuropathol Appl Neurobiol 2019;45:141
-
Cannabidiol enhances MOR antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
Authors: Rodríguez-Muñoz Et al.
Mol Brain 2018;11:51
-
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.
Authors: Esposito Et al.
Proc Natl Acad Sci U S A 2011;6:e28668
-
Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.
Authors: Hamtiaux Et al.
PLoS One 2011;6:e26823
-
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Authors: Whyte Et al.
PLoS One 2009;106:16511
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for (-)-Cannabidiol
There are currently no reviews for this product. Be the first to review (-)-Cannabidiol and earn rewards!
Have you used (-)-Cannabidiol?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image